About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Smarcb1tm2Sho
targeted mutation 2, Stuart Orkin
MGI:2447707
Summary 8 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Smarcb1tm2Sho/Smarcb1+
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre)#Gtm/0
involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA MGI:5771803
cn2
Smarcb1tm2Sho/Smarcb1+
Trp53tm1Brn/Trp53+
Tg(GFAP-cre)#Gtm/0
involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA MGI:5771802
cn3
Smarcb1tm2Sho/Smarcb1tm2Sho
Trp53tm1Brn/Trp53+
Tg(GFAP-cre)#Gtm/0
involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA MGI:5771804
cn4
Smarcb1tm2Sho/Smarcb1tm2Sho
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre)#Gtm/0
involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA MGI:5771805
cn5
Smarcb1tm1Sho/Smarcb1tm2Sho
Tg(Mx1-cre)1Cgn/?
involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA MGI:3819384
cn6
Smarcb1tm2Sho/Smarcb1tm2Sho
Tg(GFAP-cre)#Gtm/0
involves: 129S1/Sv * C57BL/6 * CBA MGI:5771801
cn7
Smarcb1tm2Sho/Smarcb1+
Tg(Nes-cre)1Kln/0
involves: 129S1/Sv * C57BL/6 * SJL MGI:5771800
cn8
Smarcb1tm2Sho/Smarcb1tm2Sho
Tg(Nes-cre)1Kln/0
involves: 129S1/Sv * C57BL/6 * SJL MGI:5771799


Genotype
MGI:5771803
cn1
Allelic
Composition
Smarcb1tm2Sho/Smarcb1+
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre)#Gtm/0
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1tm2Sho mutation (0 available); any Smarcb1 mutation (22 available)
Tg(GFAP-cre)#Gtm mutation (0 available)
Trp53tm1Brn mutation (18 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• excessive scratching behavior resulting in dermatitis around the neck, earlobes, and the flank region




Genotype
MGI:5771802
cn2
Allelic
Composition
Smarcb1tm2Sho/Smarcb1+
Trp53tm1Brn/Trp53+
Tg(GFAP-cre)#Gtm/0
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1tm2Sho mutation (0 available); any Smarcb1 mutation (22 available)
Tg(GFAP-cre)#Gtm mutation (0 available)
Trp53tm1Brn mutation (18 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• excessive scratching behavior resulting in dermatitis around the neck, earlobes, and the flank region




Genotype
MGI:5771804
cn3
Allelic
Composition
Smarcb1tm2Sho/Smarcb1tm2Sho
Trp53tm1Brn/Trp53+
Tg(GFAP-cre)#Gtm/0
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1tm2Sho mutation (0 available); any Smarcb1 mutation (22 available)
Tg(GFAP-cre)#Gtm mutation (0 available)
Trp53tm1Brn mutation (18 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• lesions in the white matter of the corpus callosum and cingulum

neoplasm
N
• no neoplastic growth is seen in the brain




Genotype
MGI:5771805
cn4
Allelic
Composition
Smarcb1tm2Sho/Smarcb1tm2Sho
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre)#Gtm/0
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1tm2Sho mutation (0 available); any Smarcb1 mutation (22 available)
Tg(GFAP-cre)#Gtm mutation (0 available)
Trp53tm1Brn mutation (18 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• many mice appear lethargic with hind limb paralysis
• severe scratching behavior
• mice exhibit intermittent episodes of tail extension and dystonic posturing of the body, frequently in response to handling
• motor coordination problems become evident from around 3 weeks of age
• abnormal posture of the hind limbs
• mice exhibit tumbling repeatedly during attempted locomotion; mice frequently fall over and repeatedly lift and replace the same paw in various positions during each stride
• severe ataxia
• mice exhibit a non-uniform gait, with uneven stride length and width, dragging of the hindpaws and an inability to keep the hindquarters upr
• uneven stride length
• many mice appear lethargic with hind limb paralysis
• mice exhibit clear seizures or intermittent electrographic seizures associated either with forelimb clonus, evolving into body jerking, and wild running or arrest of activity during the ictal EEG discharges

cellular
• altered granule neuron migration, with some granule neurons failing to migrate out of the external germinal layer, others remaining trapped in the molecular layer
• altered cerebellar granule neuron migration is already seen at 3 weeks of age

growth/size/body
• body weight is reduced by about 40%

mortality/aging
• mice require water gel for survival

muscle
• mice exhibit intermittent episodes of tail extension and dystonic posturing of the body, frequently in response to handling

neoplasm
• mice develop brain tumors starting at around 1 month of age
• mice that die suddenly exhibit presence of high-grade, aggressive tumors that infiltrate and obliterate the surrounding cerebellar folia
• tumors appear to arise from the cerebellum
• tumors show hallmarks of atypical teratoid/rhabdoid tumor of the central nervous system

nervous system
• mice exhibit clear seizures or intermittent electrographic seizures associated either with forelimb clonus, evolving into body jerking, and wild running or arrest of activity during the ictal EEG discharges
• altered granule neuron migration, with some granule neurons failing to migrate out of the external germinal layer, others remaining trapped in the molecular layer
• altered cerebellar granule neuron migration is already seen at 3 weeks of age
• mice develop brain tumors starting at around 1 month of age
• mice that die suddenly exhibit presence of high-grade, aggressive tumors that infiltrate and obliterate the surrounding cerebellar folia
• tumors appear to arise from the cerebellum
• tumors show hallmarks of atypical teratoid/rhabdoid tumor of the central nervous system
• defects in white matter with complete loss of tissue in regions of white matter over time
• white matter fiber tracks are reduced
• loss of white matter is already seen at 3 weeks of age
• defects in the corpus callosum
• lesions in the corpus callosum are already seen at 3 weeks of age
• defects in the hippocampus
• reduced cerebral cortex is already seen at 3 weeks of age
• defects in the cytoarchitecture of the cerebellum
• progressive loss of cells and neuronal projections in the cerebellum
• the boundary between the internal granule layer and the molecular layer remains diffuse
• loss of oligodendrocytes with age
• high level of gliosis in the fiber tracks and in the molecular layer and in the remnants of the external germinal layer

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
central nervous system cancer DOID:3620 J:226786




Genotype
MGI:3819384
cn5
Allelic
Composition
Smarcb1tm1Sho/Smarcb1tm2Sho
Tg(Mx1-cre)1Cgn/?
Genetic
Background
involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1tm1Sho mutation (0 available); any Smarcb1 mutation (22 available)
Smarcb1tm2Sho mutation (0 available); any Smarcb1 mutation (22 available)
Tg(Mx1-cre)1Cgn mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 90% mortality between 1 and 3 weeks after injection with polyI/polyC
• remaining mice die over the next 4 weeks

hematopoietic system
• deficiency of hematopoietic cells in the bone marrow
• mice are ill and profoundly pancytopenic by weeks 1-2 after polyI/polyC injection
• some mice develop mild or transient pancytopenia but still experience sudden death

cardiovascular system
• extensive skin bruising

digestive/alimentary system




Genotype
MGI:5771801
cn6
Allelic
Composition
Smarcb1tm2Sho/Smarcb1tm2Sho
Tg(GFAP-cre)#Gtm/0
Genetic
Background
involves: 129S1/Sv * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1tm2Sho mutation (0 available); any Smarcb1 mutation (22 available)
Tg(GFAP-cre)#Gtm mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• variable, mild defect in granule neuron migration
• brain lesions that are prominent in the white matter of the corpus callosum with vacuolization, spongy changes, cystic-like breakdown and destruction of tissue
• extent of damage is variable and progresses with age
• posterior portion of the corpus callosum is more affected than the anterior portion
• disorganization of the Purkinje cell layer
• loss of axons
• loss of myelin

cellular
• variable, mild defect in granule neuron migration

neoplasm
N
• mice do not develop brain tumors up to more than 1 year of age




Genotype
MGI:5771800
cn7
Allelic
Composition
Smarcb1tm2Sho/Smarcb1+
Tg(Nes-cre)1Kln/0
Genetic
Background
involves: 129S1/Sv * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1tm2Sho mutation (0 available); any Smarcb1 mutation (22 available)
Tg(Nes-cre)1Kln mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• most embryos die in utero

reproductive system




Genotype
MGI:5771799
cn8
Allelic
Composition
Smarcb1tm2Sho/Smarcb1tm2Sho
Tg(Nes-cre)1Kln/0
Genetic
Background
involves: 129S1/Sv * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Smarcb1tm2Sho mutation (0 available); any Smarcb1 mutation (22 available)
Tg(Nes-cre)1Kln mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/09/2024
MGI 6.23
The Jackson Laboratory